As shown in Figure 12, the protein expression levels of GFAP, AQP4, IL-1β, and TNF-α were significantly upregulated after 1.1 μM Aβ1–42 treatment for 6 hours compared with those of the AD model group, and these results were similar to those of the mRNA expression analysis. This evidence concerns the gene GFAP and Alzheimer disease.